幹細胞のようなCD4+T細胞は,T細胞状態の移行を介し,腫瘍制御と免疫療法の反応を強化する
Mamali Das1, Chandramohan Kiruthiga1, Nachammai Kathiresan2
1Department of Biomedical Science, Alagappa University, Karaikudi 630003, Tamil Nadu, India.
International immunopharmacology
|September 1, 2025
まとめ
幹細胞のようなCD4+T細胞は,抗腫瘍免疫に不可欠であり,長期的な反応と腫瘍の回復を促します. 癌の免疫療法を改善し,再発を防ぐには,その機能と相互作用を理解することが重要です.
科学分野:
- 免疫学
- 癌 生物学
- 細胞免疫学
背景:
- 免疫療法の突破は,抗腫瘍免疫における幹細胞のようなCD4+T細胞の重要な役割を強調しています.
- これらの自己再生型T細胞は 効果状態に微分化し 腫瘍内の免疫反応を維持します
- 特徴的な表面タンパク質と転写プロファイルは,腫瘍制御のためのT細胞の移行を容易にする.
研究 の 目的:
- 幹細胞のようなCD4+T細胞の表型および機能的特性を検討する.
- 状態の移行と腫瘍の微小環境の相互作用のメカニズムを探求する.
- 腫瘍の逆行,免疫療法,抵抗の克服におけるこれらの細胞の役割を調べる.
主な方法:
- 幹細胞のようなCD4+T細胞に関する最近の証拠を統合した文献レビュー.
- 信号経路と潜在的な治療介入の分析
- チェックポイント阻害剤と CAR-T細胞治療に重点を置く
主要な成果:
- 幹細胞のようなCD4+T細胞は,抗腫瘍免疫の開始と維持に不可欠です.
- 腫瘍の微小環境における適応と持続的な免疫反応を可能にします
- これらの細胞は,現在の免疫療法によって媒介される腫瘍の逆行に中心的です.
結論:
- 幹細胞のようなCD4+T細胞は,効果的ながん免疫療法に不可欠です.
- これらの細胞とそれらの相互作用をターゲットにすることで 腫瘍の制御と抵抗を克服する可能性を高めます
- 治療の可能性を最大限に活用するには さらに研究と臨床翻訳が必要です
関連する概念動画
Tumor Immunotherapy
659
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
659
T Cell Activation and Clonal Selection
4.5K
T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...
Naive T cells that have not yet encountered an antigen express two primary CD...
4.5K
T Cell Types and Functions
1.4K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.4K
Cytotoxic T Cells-mediated Immune Response
1.9K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.9K
Cell-mediated Immune Responses
72.2K
Overview
72.2K
Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K


